Whitefort Capital Management, LP In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Whitefort Capital Management, LP reported 16 stock positions worth $143.4 million . Its top holding was Arbutus Biopharma (ABUS) at 27.7% of the portfolio, followed by Roivant Sciences (ROIV, 17.6% ) and Nextnav (NN, 8.5% ). Compared with Q1 2024, it opened 4 new positions, sold out of 1, added to 3 and reduced 2. The biggest buy was Arbutus Biopharma (ABUS, shares +0% ) and the biggest sale Global Ship Lease Class A (GSL, shares −81% ).
Location NEW YORK, NY
CIK 0001884931
Portfolio Value $143.4M (Q2 2024) Holdings 16 stocks · $143.4M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2024 ABUS Arbutus Biopharma Corp. 12,867,967 $39.8M Add +0.1% ROIV Roivant Sciences Ltd. 2,391,000 $25.3M No change NN Nextnav Inc. 1,500,654 $12.2M Add +16.6% GNW Genworth Financial Inc. 1,996,960 $12.1M No change GSL Global Ship Lease Inc. Class A 366,771 $10.6M Reduce -81.5% LSXMK Liberty Media Corp.-Liber-New 456,285 $10.1M No change LQDA Liquidia Corp. 774,479 $9.3M Add +129.4% JOYY Joyy Inc.-ADR 210,946 $6.3M New ESPR Esperion Therapeutics Inc. 2,299,121 $5.1M New MHLD Maiden Holdings Ltd. 2,048,163 $4.2M No change OMEX Odyssey Marine Exploration 548,909 $2.7M No change CORZ Core Scientific Inc. 262,500 $2.4M New PBI Pitney Bowes Inc. 373,500 $1.9M No change VATE Innovate Corp. 1,288,917 $779K Reduce -35.2% OPK Opko Health Inc. 403,190 $504K New TRINITY BIOTECH INVT LTD 81,902 $174K No change
Other holdings (7): bonds, preferreds, convertibles and warrants · $18.9M (not counted above) Security Class Shares / Principal Value Change ESPERION THERAPEUTICS (ESPR 4 11/15/25) NOTE 4.000%11/1 · principal 8,000,000 $7.4M Add +100.0% SABRE GLBL INC (SABHLD 4 04/15/25) NOTE 4.000% 4/1 · principal 5,000,000 $4.8M No change INNOVATE CORP (VATE 7.5 08/01/26 *) NOTE 7.500% 8/0 · principal 8,658,000 $3.0M Add +53.0% CORZZ Core Scientific Inc. - 29 *W EXP 01/23/202 250,000 $2.2M New NNAVW Nextnav Inc. *W EXP 99/99/999 482,951 $1.5M No change AEAEW Altenergy Acquisition -CW23 *W EXP 10/29/202 186,315 $4K No change LANWF Lanvin Group Holdings Ltd.-27 *W EXP 01/14/202 100,000 $4K No change
Total filed on the 13F, all lines: $162.2M.
Portfolio Sells Q1 2024 → Q2 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▲ GSL Global Ship Lease Inc. Class A Reduce -81.5% 7.36% −18.83 LLYVK Liberty Media Corp.-Liberty-C Sold out 0.00% −3.26 VATE Innovate Corp. Reduce -35.2% 0.54% −0.37
Portfolio Buys Q1 2024 → Q2 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▼ ABUS Arbutus Biopharma Corp. Add +0.1% 27.73% +6.08 JOYY Joyy Inc.-ADR New 4.43% +4.43 ESPR Esperion Therapeutics Inc. New 3.56% +3.56 LQDA Liquidia Corp. Add +129.4% 6.48% +3.23 NN Nextnav Inc. Add +16.6% 8.49% +2.96 CORZ Core Scientific Inc. New 1.70% +1.70 OPK Opko Health Inc. New 0.35% +0.35
Notes & Other Activity Q1 2024 → Q2 2024 Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 18 $391.6M ABUS, ROIV, JOYY, BALY, GNW Q1 2026 17 $316.6M ABUS, ROIV, JOYY, SOC, GNW Q4 2025 15 $317.7M ABUS, ROIV, BALY, OABI, JOYY Q3 2025 14 $287.4M ABUS, ROIV, GNW, JOYY, OABI Q2 2025 Amended 14 $239.0M JOYY, ROIV, ABUS, GNW, OABI Q1 2025 11 $185.2M ABUS, ROIV, JOYY, GNW, LQDA Q4 2024 13 $191.5M ABUS, ROIV, LQDA, GNW, CDZI Q3 2024 13 $201.5M ABUS, EDR, ROIV, JOYY, GNW Q2 2024 16 $143.4M ABUS, ROIV, NN, GNW, GSL Q1 2024 13 $153.2M GSL, ABUS, ROIV, LSXMK, GNW